Cart
sales@molnova.com
CAPS
CAS No. 1135-40-6
CAPS( —— )
Catalog No. M35875 CAS No. 1135-40-6
CAPS (N-Cyclohexyl-3-aminopropanesulfonic acid) is a surfactant that acts as a chemiluminescence enhancer and can be used in the development of deep-sea in situ analyzers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCAPS
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAPS (N-Cyclohexyl-3-aminopropanesulfonic acid) is a surfactant that acts as a chemiluminescence enhancer and can be used in the development of deep-sea in situ analyzers.
-
DescriptionCAPS, cyclohexylaminopropane sulfonic acid, is a surfactant. CAPS can be used as biological buffer (0.05 M, pH 11) for dialysis.
-
In VitroCAPS surfactant bears a single neyative charge since the amine is not ionized at high pH.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1135-40-6
-
Formula Weight221.32
-
Molecular FormulaC9H19NO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 125 mg/mL (564.79 mM; Ultrasonic)DMSO : 5 mg/mL (22.59 mM; Ultrasonic )
-
SMILESOS(=O)(=O)CCCNC1CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bedard P R, et al. Ion Interaction: The Energetics and Mechanism of The Competitive Behavior Between Two Similarly Charged Molecules. 1. The Effect of Ionic Strength, Acetonitrile and Surfactant Concentration[J]. Journal of Liquid Chromatography, 1985, 8(13):2417-2443.
molnova catalog
related products
-
2(1H)-Quinoxalinone
2(1H)-Quinoxalinone is a natural product extracted from edible flowers such as Clitoria ternatea and Hibiscus rosa sinensis.
-
NSC 31152
NSC 31152 is a bioactive chemical.
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
